Market Size -
The CRISPR gene editing market size has grown exponentially in recent years. It will grow from $1.78 billion in 2023 to $2.26 billion in 2024 at a compound annual growth rate (CAGR) of 26.9%. The growth in the historic period can be attributed to increased demand for genome editing technologies, rise in government funding, increased cancer cases, increased prevalence of chronic diseases, increased awareness about CRISPR technology, rise healthcare infrastructure.
The CRISPR gene editing market size is expected to see exponential growth in the next few years. It will grow to $5.92 billion in 2028 at a compound annual growth rate (CAGR) of 27.2%. The growth in the forecast period can be attributed to increasing prevalence of genetic disorders, growing emphasis on precision medicine, rising investment in CRISPR research and development, increasing geriatric population, growing prominence for the gene therapy procedures. Major trends in the forecast period include advancements in gene editing technology, expansion in the number of research studies, drug discovery and development, innovation in delivery methods, adoption of CRISPR-edited agriculture.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/crispr-gene-editing-global-market-report
Scope Of CRISPR Gene Editing Market
The Business Research Company's reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market's historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
CRISPR Gene Editing Market Overview
Market Drivers -
The increasing prevalence of genetic disorders is expected to propel the growth of the CRISPR gene editing market going forward. A genetic disorder is a health problem caused by genome abnormalities, which include mutations in a single gene (monogenic), multiple genes (polygenic), or chromosomal abnormalities. The prevalence of genetic disorders is increasing due to genetic mutations, aging populations, and consanguineous marriage. CRISPR gene editing significantly aids in managing genetic disorders by providing precise and targeted modifications to the DNA. Further, scientists use CRISPR to identify and correct specific mutations causing genetic disorders, restore normal function, and alleviate disease symptoms, as seen in conditions such as cystic fibrosis and sickle cell anemia. For instance, in April 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, about 6,000 babies born in the United States have Down syndrome each year, which occurs in about 1 in every 700 babies. Therefore, the increasing prevalence of genetic disorders is driving the growth of the CRISPR gene editing market.
Market Trends -
Major companies operating in the CRISPR gene editing market are focused on developing innovative products, such as CRISPR gene editing tools, to provide researchers with reliable and efficient solutions, enabling rapid and simplified analysis of gene editing experiments. CRISPR gene editing tools are a solution for CRISPR genome editing experiments that will allow researchers to study edited genetic material with unprecedented speed and efficiency, determining how their interventions have altered the function of the DNA sequence in question. For instance, in June 2021, QIAGEN, a Germany-based provider of sample and assay technologies for molecular diagnostics, academic research, and pharmaceutical research, launched the QIAprep& and CRISPR Kit and CRISPR Q-Primer. These tools are designed to determine cells edited with CRISPR technologies, offering a sensitive, all-in-one solution for defining knock-outs and knock-ins produced during gene editing. The QIAprep&CRISPR Kit and CRISPR Q-Primer Solutions integrate liquid-based sample preparation with downstream PCR detection and Sanger sequencing, resulting in a seven-day reduction in experiment time compared to conventional approaches.
The CRISPR gene editing market covered in this report is segmented -
1) By Type: CRISPR-Associated Nuclease (Cas Nuclease), Guide Ribonucleic Acid (RNA), Deoxyribonucleic Acid (DNA) Ligase, Restriction Endonuclease, Other Types
2) By Services: Design Tools, Plasmid And Vector, CRISPR-Associated Protein 9 (Cas9) And Guide Ribonucleic Acid (g-RNA), Delivery System Products, Other Services
3) By Technology: CRISPR Or Cas9, Zinc Finger Nucleases, Other Technologies
4) By Application: Agricultural, Biomedical , Industrial, Genome Engineering, Disease Models, Functional Genomics, Other Applications
5) By End User: Academic Institutes And Research Centers, Biotechnology Companies, Contract Research Organizations (CROs), Pharmaceutical And Biopharmaceutical Companies
Get an inside scoop of the crispr gene editing market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=15549&type=smp
Regional Insights -
North America was the largest region in the CRISPR gene editing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the CRISPR gene editing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies -
Major companies operating in the CRISPR gene editing market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., GenScript, Integrated DNA Technologies Inc., Takara Bio Inc., OriGene Technologies Inc., Intellia Therapeutics Inc., New England Biolabs, Synthego, Arbor Biotechnologies Inc., Rockland Immunochemicals Inc., Cellectis, Editas Medicine, Caribou Biosciences Inc., System Biosciences LLC, Applied StemCell, Addgene, Mirus Bio LLC, Excision BioTherapeutics Inc., GeneCopoeia Inc., ToolGen Inc., Cellecta Inc., CRISPR Therapeutics, ERS Genomics Limited
Table of Contents
1. Executive Summary
2. CRISPR Gene Editing Market Characteristics
3. CRISPR Gene Editing Market Trends And Strategies
4. CRISPR Gene Editing Market - Macro Economic Scenario
5. Global CRISPR Gene Editing Market Size and Growth
.
.
.
31. CRISPR Gene Editing Market Other Major And Innovative Companies
32. Global CRISPR Gene Editing Market Competitive Benchmarking
33. Global CRISPR Gene Editing Market Competitive Dashboard
34. Key Mergers And Acquisitions In The CRISPR Gene Editing Market
35. CRISPR Gene Editing Market Future Outlook and Potential Analysis
36.Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
To know the trends and opportunities in CRISPR gene-editing industry, CRISPR gene-editingmarket research document is the best solution to go for.
This report presents broader perspective of the market place with its comprehensive market insights and analysis.
This business report provides all-inclusive knowledge and information of swiftly changing market landscape, what already subsists in the market, future trends or market expectations, the competitive environment, and competitor strategies that aids in planning business strategies and outshine the competitors.
The CRISPR gene-editing report gives details about market analysis, market definition, market segmentation, key development areas,competitive analysis and research methodology.Global CRISPR gene-editing market is rising gradually with a healthy CAGR of 23.35 % in the forecast period of 2019-2026This business report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market.
To understand the analysis and the market scenario presented in this report, DBMR team is always there to help and create a revenue impact solution to achieve desired goal.
In this promotional report, CRISPR gene-editing market is segmented on the basis of product, indication, application, and end user.Due to the pandemic, we have included a special section on the Impact of COVID 19 on the CRISPR gene-editing Market which would mention How the Covid-19 is affecting the CRISPR gene-editing Industry, Market Trends and Potential Opportunities in the COVID-19 Landscape, Covid-19 Impact on Key Regions and Proposal for CRISPR gene-editing Players to Combat Covid-19 Impact.Get Sample PDF of CRISPR gene-editing Market Report (including COVID19 Impact Analysis) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-crispr-gene-editing-marketMarket Drivers and Restraints:High prevalence of cancer worldwide is driving the growth of this marketJoint ventures by biotechnical companies for the advancement of genetic engineering for the development of CRISPR worldwide can also boost the market growthExpanding the application of CRISPR technology by innovative research from the different academic organizations also enhances the market growthHigh finance in research and development also acts as a driving factor in the growth of this marketProbable mistreatment of CRISPR gene editing device and CRISPR/Cas genome editing device is restricting the growth for the marketScientific and major technical challenges for the production of disease specific novel CRISPR gene editing can also hamper the market growthLack of healthcare budget in some middle-income countries restricts the market growthKey Players: Global CRISPR gene-editing MarketApplied StemCell, ACEA BIO, Synthego, Thermo Fisher Scientific Inc, GenScript, Addgene, Merck KGaA, Intellia Therapeutics, Inc, Cellectis, Precision Biosciences, Caribou Biosciences, Inc, Transposagen Biopharmaceuticals, Inc, OriGene Technologies, Inc, Novartis AG, New England Biolabs among othersMAJOR TOC OF THE REPORTChapter One: CRISPR gene-editing Market OverviewChapter Two: Manufacturers ProfilesChapter Three: Global CRISPR gene-editing Market Competition, by PlayersChapter Four: Global CRISPR gene-editing Market Size by RegionsChapter Five: Global CRISPR gene-editing Market Revenue by CountriesChapter Six: Global CRISPR gene-editing Market Revenue by Therapeutic Application (Oncology, Autoimmune/Inflammatory)Chapter Seven: Global CRISPR gene-editing Market Revenue by Application (Genome Engineering, Disease Models, Functional Genomics and Others)Chapter Eight: Global CRISPR gene-editing Market Revenue by Technology (CRISPR/Cas9, Zinc Finger Nucleases and Others)Chapter Nine: Global CRISPR gene-editing Market Revenue by Services (Design Tools, Plasmid and Vector, Cas9 and g-RNA, Delivery System Products and Others)Chapter Ten: Global CRISPR gene-editing Market Revenue by Products (GenCrispr/Cas9 kits, GenCrispr Cas9 Antibodies, GenCrispr Cas9 Enzymes and Others)Chapter Eleven: Global CRISPR gene-editing Market Revenue by End-Users (Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, Contract Research Organizations and Others)Get Detail TOC@ https://www.databridgemarketresearch.com/toc/?dbmr=global-crispr-gene-editing-marketKey Report HighlightsComprehensive pricing analysis based on different product types and regional segmentsMarket size data in terms of revenue and sales volumeDeep insights about regulatory and investment scenarios of the global CRISPR gene-editing MarketAnalysis of market effect factors and their impact on the forecast and outlook of the global CRISPR gene-editing MarketThe detailed assessment of the vendor landscape and leading companies to help understand the level of competition in the global CRISPR gene-editing MarketA roadmap of growth opportunities available in the Global CRISPR gene-editing Marketwith the identification of key factorsThe exhaustive analysis of various trends of the Global CRISPR gene-editing Marketto help identify market developmentsKey Questions Answered in Report:What is the key to the CRISPR gene-editing Market?What will the CRISPR gene-editing Market Demand and what will be Growth?What are the latest opportunities for CRISPR gene-editing Market in the future?What are the strengths of the key players?Which region accounted for the largest CRISPR gene-editing market share?Access Full Report @ https://www.databridgemarketresearch.com/reports/global-crispr-gene-editing-marketAbout Us:Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches.
